Combination therapy with rituximab and fludarabine in Waldenstrom's Macroglobulinemia.

被引：6
|
作者：
Treon, SP
Branagan, A
Wasi, P
Emmanouilides, CA
Frankel, SR
Lister, A
Morel, P
Matous, J
Enschede, SH
Kimby, E
机构：
[1] Dana Farber Canc Inst, Bing Program Waldenstroms Macrolgobulinemia, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] McMaster Univ, Med Ctr, Hamilton, ON, Canada
[4] Univ Calif Los Angeles, Ctr Med, Los Angeles, CA 90024 USA
[5] Greenbaum Canc Ctr, Baltimore, MD USA
[6] St Bartholomews Hosp & Canc Res, London, England
[7] Ctr Hosp Schaffner, Lens, France
[8] Mt Canc Ctr, Denver, CO USA
[9] Rush Presbyterian Med Ctr, Chicago, IL USA
[10] Karolinska Inst, Stockholm, Sweden
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.753.753
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
753
引用
收藏
页码：215A / 215A
页数：1
相关论文
共 50 条
  • [31] Rituximab alone or in combination in the frontline treatment of Waldenstrom's macroglobulinemia
    Weber, D. M.
    Thomas, S.
    Wang, M.
    Alexanian, R.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 87 - 88
  • [32] Long-term outcomes to fludarabine and rituximab in Waldenstrom macroglobulinemia
    Treon, Steven P.
    Branagan, Andrew R.
    Ioakimidis, Leukothea
    Soumerai, Jacob D.
    Patterson, Christopher J.
    Turnbull, Barry
    Wasi, Parveen
    Emmanouilides, Christos
    Frankel, Stanley R.
    Lister, Andrew
    Morel, Pierre
    Matous, Jeffrey
    Gregory, Stephanie A.
    Kimby, Eva
    [J]. BLOOD, 2009, 113 (16) : 3673 - 3678
  • [33] Clarithromycin, thalidomide and dexamethasone for the treatment of Waldenstrom's macroglobulinemia.
    Dimopoulos, MA
    Tsatalas, C
    Zomas, A
    Hamilos, G
    Panayiotidis, P
    Anagnostopoulos, N
    Gika, D
    Margaritis, D
    Economopoulos, T
    [J]. BLOOD, 2002, 100 (11) : 384B - 384B
  • [34] Cutaneous immunocytoma in Waldenstrom macroglobulinemia.
    Alliot, C
    Tabuteau, S
    Fernandes, J
    Garidi, R
    Desablens, B
    [J]. SEMAINE DES HOPITAUX, 1999, 75 (15-16): : 480 - 480
  • [35] Interstitial pneumonitis related to rituximab therapy for Waldenstrom's macroglobulinemia
    Bai, Xueyan
    Cui, Qu
    Liu, Yuanbo
    [J]. CLINICAL CASE REPORTS, 2015, 3 (02): : 133 - +
  • [36] A novel murine model for human Waldenstrom's macroglobulinemia.
    Tassone, P
    Neri, P
    Kutok, J
    Tournilhac, O
    Santos, DD
    Hatjiharissi, E
    Venuta, S
    Anderson, KC
    Treon, S
    Munshi, NC
    [J]. BLOOD, 2004, 104 (11) : 991A - 991A
  • [37] Ibrutinib and Rituximab in Waldenstrom's Macroglobulinemia
    Olszewski, Adam J.
    Castillo, Jorge J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (20): : 1973 - 1974
  • [38] Autoimmune thrombocytopenia: a complication of fludarabine therapy in the treatment of Waldenstrom's macroglobulinemia
    Jiang, Yujie
    Peng, Hongjuan
    Cui, Xin
    Zhou, Ying
    Yuan, Dai
    Sui, Xiaohui
    Zhang, Lingyan
    Xu, Hongzhi
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (12): : 5937 - 5942
  • [39] Treatment of Waldenstrom's macroglobulinemia with rituximab
    Dimopoulos, MA
    Zervas, C
    Zomas, A
    Kiamouris, C
    Viniou, NA
    Grigoraki, V
    Karkantaris, C
    Mitsouli, C
    Gika, D
    Christakis, J
    Anagnostopoulos, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (09) : 2327 - 2333
  • [40] Hyaluronan synthases may potentiate Waldenstrom's macroglobulinemia.
    Adamia, S
    Kriangkum, J
    Crainie, M
    Belch, AR
    Mant, MJ
    Pilarski, LM
    [J]. BLOOD, 2002, 100 (11) : 199B - 199B
12345